SEQUENT SCIENTIFIC
Back to Income Statement
|
SEQUENT SCIENTIFIC Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹22 Cr | ₹-36 Cr | ₹-121 Cr | ₹41 Cr | ₹95 Cr |
What is the latest Consolidated Net Profit of SEQUENT SCIENTIFIC ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹22 Cr |
| Mar2024 | ₹-36 Cr |
| Mar2023 | ₹-121 Cr |
| Mar2022 | ₹41 Cr |
| Mar2021 | ₹95 Cr |
How is Consolidated Net Profit of SEQUENT SCIENTIFIC Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹22 Cr | Positive | |
| Mar2024 | ₹-36 Cr | Negative | |
| Mar2023 | ₹-121 Cr | Negative | |
| Mar2022 | ₹41 Cr | -57.09 | |
| Mar2021 | ₹95 Cr | - | |
Compare Consolidated Net Profit of peers of SEQUENT SCIENTIFIC
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SEQUENT SCIENTIFIC | ₹8,004.0 Cr | 1.8% | -16.5% | 29.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹421,647.0 Cr | 0.1% | -0.4% | 0.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹157,862.0 Cr | -1.1% | -7.1% | 1.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹142,846.0 Cr | 0.2% | -4.5% | 30.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,720.0 Cr | 0.2% | -4% | 6% | Stock Analytics | |
| CIPLA | ₹98,795.9 Cr | 0% | -9.1% | -18.5% | Stock Analytics | |
SEQUENT SCIENTIFIC Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SEQUENT SCIENTIFIC | 1.8% |
-16.5% |
29.3% |
| SENSEX | -3.5% |
-12.5% |
-6.5% |
You may also like the below Video Courses